One possible explanation is that since IGFBP-7 binds IGF ligands with less affinity that the other six IGFBPs [78], the regulation of IGFBP-7 in response to treatment with AD might have a different mechanism. The gene discussed is IGFBP7; the disease is Alzheimer disease.